Apogee Therapeutics, Inc. (APGE) Form SCHEDULE 13D/A — Sep 8, 2026

$APGEForm SCHEDULE 13D/AFiled Sep 8, 2026, 5:08 PM ET0001231919-26-001150Original filing

A Venrock Healthcare Capital Partners investment group, together with individual Bong Koh, filed a Schedule 13D/A amendment dated September 8, 2026 with respect to common stock of Apogee Therapeutics, Inc. The provided exhibits are administrative: powers of attorney appointing Jessica Baron, Evan W. Neu and Sherman G. Souther, Jr.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.